Importantly, however, we have demonstrated in MVID patient–derived enteroids that the epithelial defects in MVID can be reversed and that loss of MYO5B function can be bypassed by targeting of pathways affected by γ-secretase inhibition. Here, MYO5B is linked to microvillus inclusion disease.